## CBOE: Cboe Global Markets, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -1.4% below STRENGTH zone (3.0-6.0%); PEG 2.11 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($241.90)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Baird Financial Group Inc. Increases Stock Holdings in Cboe Global Markets, Inc. $CBOE**
- Source: MarketBeat | 20251210T090114 | Bullish | Relevance: 99%
-  Baird Financial Group Inc. significantly increased its stake in Cboe Global Markets, Inc. by 21.3% during Q2, bringing its total holdings to 27,148 shares valued at $6.33 million. Other major institutions like Vanguard, AllianceBernstein, and Invesco also boosted their positions, resulting in institutional investors owning approximately 82.67% of CBOE. Cboe recently beat EPS estimates, reported a 13.8% year-over-year revenue increase, and declared a $0.72 dividend, while analysts maintain a "Hold" rating with a consensus price target of $243.38.

**2. Cboe Global Markets Announces Date of Fourth-Quarter 2025 Earnings Release and Conference Call**
- Source: StreetInsider | 20251210T211017 | Neutral | Relevance: 99%
-  Cboe Global Markets, Inc. announced that it will release its fourth-quarter 2025 financial results on Friday, February 6, 2026, before the market opens. A conference call with senior management will follow at 7:30 a.m. CT (8:30 a.m. ET) and a live audio webcast will be available on the company's Investor Relations website. The presentation and a replay of the call will also be archived on the website.

**3. CBOE: Strategic pivot to core growth, event contracts, and disciplined reinvestment drives strong results**
- Source: TradingView | 20251209T154455 | Bullish | Relevance: 99%
-  CBOE Management is undergoing a strategic realignment, focusing on high-growth areas such as SPX options and event contracts, while divesting non-core businesses. The company prioritizes expense discipline and reinvestment in core segments, showing strong growth in products like SPX, zero DTE, and Data Vantage. This strategy aims to drive strong results by focusing on key growth areas.

**4. Natixis Purchases 10,799 Shares of Cboe Global Markets, Inc. $CBOE**
- Source: MarketBeat | 20251210T113313 | Somewhat-Bullish | Relevance: 99%
-  Natixis significantly increased its stake in Cboe Global Markets (NASDAQ:CBOE) by 98.7% in Q2, acquiring an additional 10,799 shares for a total of 21,739 shares now valued at approximately $5.07 million. Institutional investors collectively own 82.67% of Cboe's stock, with notable activity from Invesco and Nuveen. Despite a consensus "Hold" rating from analysts with an average price target of $243.38, Cboe recently announced a $0.72 dividend.

**5. Cboe Global Markets Announces Date of Fourth-Quarter 2025 Earnings Release and Conference Call**
- Source: WJBF | 20251210T163000 | Neutral | Relevance: 99%
-  Cboe Global Markets, Inc. will release its fourth-quarter 2025 financial results before market open on Friday, February 6, 2026. A conference call with senior management will follow at 7:30 a.m. CT (8:30 a.m. ET), with a live audio webcast available on the Investor Relations section of Cboe's website. The presentation will be archived for replay on the company's website.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (+0.0%)
- Blackrock Inc.: 9.0% (-2.7%)
- Alliancebernstein L.: 6.1% (-31.2%)
- State Street Corpora: 4.5% (+2.1%)
- FMR, LLC: 4.3% (+62.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.11 elevated, pricing in significant growth expectations. Forward P/E 23.2x stretched relative to 4% growth. Quality metrics strong (ROE 22%, margin 21%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.3B |
| Beta | 0.35 |
| 52W Range | $187.30 - $262.98 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.11 |
| Forward P/E | 23.2 |
| Current P/E | 24.2 |
| YoY Growth | 4.5% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -2.6% to -1.4% (+1.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.4pp (needs >3.0% for momentum thesis). Underperforming sector by 3.2pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). MACD histogram bearish (-1.20), momentum weakening. RSI neutral at 47.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.39% (CS: 22) | Neutral |
| RSI_14 | 47.2 | Neutral |
| MACD Histogram | -1.20 | Bearish |
| vs SMA20 | 0.984x | Below |
| vs SMA50 | 1.012x | Above |
| vs SMA200 | 1.074x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $251.10
- **Stop Loss:** $241.90 (3.7% risk)
- **Target:** $260.30 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 150
- **Position Value:** $37,665.00
- **Portfolio %:** 37.66%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-06 (Est: $2.73)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.53 | $2.67 | +5.6% |
| 2025Q2 | $2.44 | $2.46 | +0.6% |
| 2025Q1 | $2.36 | $2.50 | +5.8% |
| 2024Q4 | $2.12 | $2.10 | -0.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*